Mikhail Eydelman
Compliance Officer at VAXCYTE, INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Mikhail Eydelman is currently working as the Secretary, Chief Compliance Officer & Senior VP at Vaxcyte, Inc. Prior to his current position, he worked as the Secretary & General Counsel at Sagent Pharmaceuticals, Inc. from 2017 to 2022.
Mr. Eydelman completed his undergraduate degree at Brandeis University and his graduate degree at New York University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXCYTE, INC.
0.03% | 31/03/2024 | 30,597 ( 0.03% ) | 2 M $ | 30/03/2024 |
Mikhail Eydelman active positions
| Companies | Position | Start |
|---|---|---|
| VAXCYTE, INC. | Compliance Officer | 31/03/2022 |
Former positions of Mikhail Eydelman
| Companies | Position | End |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | General Counsel | 31/03/2022 |
Training of Mikhail Eydelman
| Brandeis University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Stock Market
- Insiders
- Mikhail Eydelman
